<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05617807</url>
  </required_header>
  <id_info>
    <org_study_id>1926751-2</org_study_id>
    <nct_id>NCT05617807</nct_id>
  </id_info>
  <brief_title>Outcomes of the Nanoscopic Partial Meniscectomy Versus Standard Arthroscopic Partial Meniscectomy</brief_title>
  <official_title>Outcomes of the Nanoscopic Partial Meniscectomy Versus Standard Arthroscopic Partial Meniscectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Marshall University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Arthrex, Inc.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medstar Washington Hospital Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Marshall University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Standard arthroscopy has been the gold standard for treatment of meniscus tears since the&#xD;
      1980's. The purpose of this study is to analyze the clinical outcomes of using the smaller&#xD;
      diameter Nanoscope for partial menisectomy. The authors hypothesize that the Nanoscopic&#xD;
      partial menisectomy patients will have less pain and return function faster than standard&#xD;
      arthroscopy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2022</start_date>
  <completion_date type="Anticipated">December 2023</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized Controlled Trial</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional Outcomes following partial meniscectomy: Knee Injury and Osteoarthritis Score</measure>
    <time_frame>6 weeks</time_frame>
    <description>We will be looking at functional outcomes following partial meniscectomy with the nanoscope compared to standard arthroscopy by looking at Knee Injury and Osteoarthritis Score (O -100 with higher being patients doing better functionally)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Functional Outcomes Following Partial Meniscectomy: International Knee Documentation Committee Score</measure>
    <time_frame>6 weeks</time_frame>
    <description>We will be looking at functional outcomes following partial meniscectomy with the nanoscope compared to standard arthroscopy by looking at the International Knee Documentation Committee Score (0-100 with higher being patients doing better functionally)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain: Visual Analog Pain Score</measure>
    <time_frame>6 weeks</time_frame>
    <description>Pain following partial meniscectomy with the nanoscope compared to standard arthroscopy using Visual Analog Pain Score (0-10 with 0 being no pain and 10 being the worst pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Narcotic Medication Use</measure>
    <time_frame>24 hours</time_frame>
    <description>we will be looking at the amount of narcotic pain medication used following nanoscopic partial meniscectomy compared to standard arthroscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Return to work</measure>
    <time_frame>6 weeks</time_frame>
    <description>time to return to work following partial meniscectomy</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Meniscus Tear</condition>
  <arm_group>
    <arm_group_label>Nanoscopic Partial Meniscectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This is the experimental group. patients will have a partial meniscectomy performed using the arthrex nanoscope</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Partial Meniscectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will have a partial meniscectomy performed using standard arthroscopic equipment which is the current gold standard</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Nanoscopic partial meniscectomy</intervention_name>
    <description>Patients will have a partial meniscectomy performed using the arthrex nanoscope and it will be compared to partial meniscectomy performed using standard arthroscopic equipment</description>
    <arm_group_label>Nanoscopic Partial Meniscectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard Partial Meniscectomy</intervention_name>
    <description>Patients will have partial meniscectomy performed using standard arthroscopic equipment</description>
    <arm_group_label>Standard Partial Meniscectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  MRI positive for meniscus tear&#xD;
&#xD;
          -  More than 3mm of joint space on PA flexion weightbearing x rays&#xD;
&#xD;
          -  Primary arthroscopy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Workers compensation&#xD;
&#xD;
          -  Older than 60 years of age&#xD;
&#xD;
          -  Revision surgeries&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shane Taylor</last_name>
    <phone>6094729212</phone>
    <email>taylorsh@marshall.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chad Lavender</last_name>
    <phone>3045526514</phone>
    <email>doclav@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>MedStar Washington Hospital Center</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Marshall Orthopaedics - Teays Valley</name>
      <address>
        <city>Scott Depot</city>
        <state>West Virginia</state>
        <zip>25560</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chad Lavender</last_name>
      <phone>304-552-6514</phone>
      <email>doclav@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Chad Lavender, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2023</verification_date>
  <study_first_submitted>November 7, 2022</study_first_submitted>
  <study_first_submitted_qc>November 12, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 16, 2022</study_first_posted>
  <last_update_submitted>February 11, 2023</last_update_submitted>
  <last_update_submitted_qc>February 11, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">February 14, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Marshall University</investigator_affiliation>
    <investigator_full_name>Shane Taylor</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Arthroscopy</keyword>
  <keyword>Meniscus</keyword>
  <keyword>Meniscectomy</keyword>
  <keyword>Nanoscopic</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

